See every side of every news story
Get Started
SubscribeLogin
Pope Francis
Olaf Scholz
Volodymyr Zelenskyy
Ukraine War
Vatican
German Politics
Donald Trump
Basketball
Israel-Hamas Conflict
Hamas
Wrestling
Baseball
Published • loading... • Updated

E2 Raises Financing to Advance Treatment of Pulmonary Embolism - Cardiac Interventions Today

Summary by Cardiac Interventions Today
February 18, 2025—Endovascular Engineering, Inc. (E2) announced it has secured $42 million in oversubscribed Series B financing to advance its next-generation clot removal technology platform for venous thromboembolism (VTE). According to the company, the funding round accelerates its VTE treatment program, with an initial focus on advancing solutions for pulmonary embolism (PE). E2 stated it seeks to address critical unmet needs in intervention…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

3 Articles

All
Left
Center
Right
Endovascular TodayEndovascular Today

E2 Raises Financing to Advance Treatment of Pulmonary Embolism - Endovascular Today

February 18, 2025—Endovascular Engineering, Inc. (E2) announced it has secured $42 million in oversubscribed Series B financing to advance its next-generation clot removal technology platform for venous thromboembolism (VTE). According to the company, the funding round accelerates its VTE treatment program, with an initial focus on advancing solutions for pulmonary embolism (PE). E2 stated it seeks to address critical unmet needs in intervention…

Read Full Article
Cardiac Interventions TodayCardiac Interventions Today

E2 Raises Financing to Advance Treatment of Pulmonary Embolism - Cardiac Interventions Today

February 18, 2025—Endovascular Engineering, Inc. (E2) announced it has secured $42 million in oversubscribed Series B financing to advance its next-generation clot removal technology platform for venous thromboembolism (VTE). According to the company, the funding round accelerates its VTE treatment program, with an initial focus on advancing solutions for pulmonary embolism (PE). E2 stated it seeks to address critical unmet needs in intervention…

Read Full Article
First10EMFirst10EM

PEERLESS: Interventional therapies for pulmonary embolism

The decision between mechanical thrombectomy and catheter directed thrombolysis for pulmonary embolism is not one that most emergency physicians are making. Most (like me) probably don’t even have access to such therapies, which might be a good thing, as both therapies remain completely unproven. However, I thought I would share the PEERLESS trial as a […] The post PEERLESS: Interventional therapies for pulmonary embolism appeared first on First…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

First10EM broke the news in on Monday, February 17, 2025.
Sources are mostly out of (0)

Similar News Topics

Maryland

Maryland

News
For You
Search
BlindspotLocal